We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFT
5076
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
-100
Closed -$2K
OSG
5077
DELISTED
Overseas Shipholding Group Inc.
OSG
-1,639
Closed -$18K
FBGX
5078
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
-177
Closed -$22K
SCPX
5079
DELISTED
Scorpius Holdings, Inc.
SCPX
0
EMFM
5080
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
$0 ﹤0.01%
+5
New +$97
CTHR
5081
DELISTED
Charles & Colvard Ltd
CTHR
$0 ﹤0.01%
9
-112
-93% -$1.24K
ENG
5082
DELISTED
ENGlobal Corp
ENG
$0 ﹤0.01%
+12
New +$116
ICD
5083
DELISTED
Independence Contract Drilling, Inc.
ICD
-16
Closed -$2K
NTG
5084
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
-245
Closed -$40K
FEN
5085
DELISTED
First Trust Energy Income and Growth Fund
FEN
-200
Closed -$5K
FEI
5086
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
-180
Closed -$2K
SMMF
5087
DELISTED
Summit Financial Group, Inc.
SMMF
-53
Closed -$1K
YTEN
5088
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
-$3K
HTY
5089
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
-105
Closed -$1K
EIGR
5090
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-3
Closed -$1K
MFV
5091
DELISTED
MFS SPECIAL VALUE TRUST
MFV
-112
Closed -$1K
CBAY
5092
DELISTED
Cymabay Therapeutics
CBAY
-5,777
Closed -$8K
VJET
5093
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
-6
Closed
FGH
5094
DELISTED
FG Group Holdings Inc.
FGH
-370
Closed -$2K
BPTH
5095
DELISTED
Bio-Path Holdings Inc
BPTH
0
-$2K
CHIE
5096
DELISTED
Global X MSCI China Energy ETF
CHIE
-496
Closed -$5K
BFIT
5097
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
$0 ﹤0.01%
+10
New +$151
NVTA
5098
DELISTED
Invitae Corporation
NVTA
-1,059
Closed -$11K
DMK
5099
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-4
Closed -$2K
GOL
5100
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-3,625
Closed -$5K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.